{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:29Z","timestamp":1787020229267,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T00:00:00Z","timestamp":1740355200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-025-04078-8","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:20:15Z","timestamp":1740360015000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Time moving 100-fold slower: time distortion as a diagnostic clue in anti-NMDA receptor encephalitis"],"prefix":"10.1186","volume":"25","author":[{"given":"Risa","family":"Hirata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Sogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroto","family":"Muzuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Isaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michitaka","family":"Funayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,24]]},"reference":[{"issue":"3","key":"4078_CR1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1007\/s00415-021-10738-9","volume":"269","author":"MS Nissen","year":"2022","unstructured":"Nissen MS, \u00d8rvik MS, Nilsson AC, Ryding M, Lydolph M, Blaabjerg M. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study. J Neurol. 2022;269(3):1618\u201330.","journal-title":"J Neurol"},{"issue":"6","key":"4078_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1111\/ane.12792","volume":"136","author":"E Ayubi","year":"2017","unstructured":"Ayubi E, Safiri S. Risk factors for mortality in patients with anti-NMDA receptor encephalitis; comment on data sparsity. Acta Neurol Scand. 2017;136(6):737.","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"4078_CR3","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangu\u00e9 T, Glaser C, Iizuka T, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12(2):157\u201365.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4078_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s40211-023-00478-9","volume":"38","author":"YR Giri","year":"2024","unstructured":"Giri YR, Parrill A, Damodar S, Fogel J, Ayed N, Syed M, et al. Anti-N-methyl-D-aspartate receptor encephalitis in adults: a systematic review and analysis. Neuropsychiatr. 2024;38(2):92\u2013101.","journal-title":"Neuropsychiatr"},{"issue":"3","key":"4078_CR5","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1176\/appi.ajp.2010.10020181","volume":"168","author":"MR Chapman","year":"2011","unstructured":"Chapman MR, Vause HE. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry. 2011;168(3):245\u201351.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"4078_CR6","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008;7(12):1091\u20138.","journal-title":"Lancet Neurol"},{"key":"4078_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","volume":"8","author":"J Herken","year":"2017","unstructured":"Herken J, Pr\u00fcss H. Red flags: clinical signs for identifying Autoimmune Encephalitis in Psychiatric patients. Front Psychiatry. 2017;8:25.","journal-title":"Front Psychiatry"},{"issue":"11","key":"4078_CR8","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(19)30244-3","volume":"18","author":"J Dalmau","year":"2019","unstructured":"Dalmau J, Armangu\u00e9 T, Planagum\u00e0 J, Radosevic M, Mannara F, Leypoldt F, et al. An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models. Lancet Neurol. 2019;18(11):1045\u201357.","journal-title":"Lancet Neurol"},{"issue":"3","key":"4078_CR9","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S2215-0366(19)30001-X","volume":"6","author":"A Al-Diwani","year":"2019","unstructured":"Al-Diwani A, Handel A, Townsend L, Pollak T, Leite MI, Harrison PJ, et al. The psychopathology of NMDAR-antibody encephalitis in adults: a systematic review and phenotypic analysis of individual patient data. Lancet Psychiatry. 2019;6(3):235\u201346.","journal-title":"Lancet Psychiatry"},{"issue":"5","key":"4078_CR10","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/acps.12941","volume":"138","author":"N Warren","year":"2018","unstructured":"Warren N, Siskind D, O\u2019Gorman C. Refining the psychiatric syndrome of anti-N-methyl-d-aspartate receptor encephalitis. Acta Psychiatr Scand. 2018;138(5):401\u20138.","journal-title":"Acta Psychiatr Scand"},{"issue":"1","key":"4078_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1176\/appi.neuropsych.17120343","volume":"31","author":"LL Gibson","year":"2019","unstructured":"Gibson LL, Pollak TA, Blackman G, Thornton M, Moran N, David AS. The Psychiatric phenotype of Anti-NMDA receptor encephalitis. J Neuropsychiatry Clin Neurosci. 2019;31(1):70\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"4078_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1176\/appi.neuropsych.18010005","volume":"31","author":"RA Sarkis","year":"2019","unstructured":"Sarkis RA, Coffey MJ, Cooper JJ, Hassan I, Lennox B. Anti-N-Methyl-D-Aspartate receptor encephalitis: a review of Psychiatric Phenotypes and Management considerations: a report of the American Neuropsychiatric Association Committee on Research. J Neuropsychiatry Clin Neurosci. 2019;31(2):137\u201342.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"2","key":"4078_CR13","doi-asserted-by":"publisher","first-page":"e01980","DOI":"10.1002\/brb3.1980","volume":"11","author":"E Gin\u00e9 Serv\u00e9n","year":"2021","unstructured":"Gin\u00e9 Serv\u00e9n E, Boix Quintana E, Mart\u00ednez Ram\u00edrez M, Guanyabens Busc\u00e0 N, Muriana Batiste D, Guasp M, et al. Cycloid psychosis as a psychiatric expression of anti-NMDAR encephalitis. A systematic review of case reports accomplished with the authors\u2019 cooperation. Brain Behav. 2021;11(2):e01980.","journal-title":"Brain Behav"},{"issue":"2","key":"4078_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/pcn.13317","volume":"76","author":"T Komagamine","year":"2022","unstructured":"Komagamine T, Kanbayashi T, Suzuki K, Hirata K, Nishino S. Atypical psychoses and anti-NMDA receptor encephalitis: a review of literature in the mid-twentieth century. Psychiatry Clin Neurosci. 2022;76(2):62\u20133.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"5","key":"4078_CR15","first-page":"e15188","volume":"13","author":"GK Subeh","year":"2021","unstructured":"Subeh GK, Lajber M, Patel T, Mostafa JA. Anti-N-Methyl-D-Aspartate receptor encephalitis: a detailed review of the different Psychiatric presentations and red flags to look for in suspected cases. Cureus. 2021;13(5):e15188.","journal-title":"Cureus"},{"issue":"1","key":"4078_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1097\/PRA.0000000000000603","volume":"28","author":"YR Giri","year":"2022","unstructured":"Giri YR, Korie I, Hashmi S, Parrill A, Ayed N. Anti-NMDA receptor Encephalitis masquerades as psychosis: a Case Report. J Psychiatr Pract. 2022;28(1):72\u20137.","journal-title":"J Psychiatr Pract"},{"issue":"4","key":"4078_CR17","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15(4):391\u2013404.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4078_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/jnnp-2011-300411","volume":"83","author":"C Finke","year":"2012","unstructured":"Finke C, Kopp UA, Pr\u00fcss H, Dalmau J, Wandinger KP, Ploner CJ. Cognitive deficits following anti-NMDA receptor encephalitis. J Neurol Neurosurg Psychiatry. 2012;83(2):195\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"4078_CR19","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1212\/NXI.0000000000000130","volume":"2","author":"S Byrne","year":"2015","unstructured":"Byrne S, Walsh C, Hacohen Y, Muscal E, Jankovic J, Stocco A, et al. Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome. Neurol Neuroimmunol Neuroinflamm. 2015;2(4):e130.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"4078_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.biopsych.2015.02.024","volume":"79","author":"C Finke","year":"2016","unstructured":"Finke C, Kopp UA, Pajkert A, Behrens JR, Leypoldt F, Wuerfel JT, et al. Structural hippocampal damage following Anti-N-Methyl-D-Aspartate receptor encephalitis. Biol Psychiatry. 2016;79(9):727\u201334.","journal-title":"Biol Psychiatry"},{"issue":"4","key":"4078_CR21","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","volume":"13","author":"WJ Lee","year":"2016","unstructured":"Lee WJ, Lee ST, Moon J, Sunwoo JS, Byun JI, Lim JA, et al. Tocilizumab in Autoimmune Encephalitis Refractory to Rituximab: an institutional cohort study. Neurotherapeutics. 2016;13(4):824\u201332.","journal-title":"Neurotherapeutics"},{"key":"4078_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.jpsychires.2022.05.008","volume":"151","author":"M Funayama","year":"2022","unstructured":"Funayama M, Koreki A, Takata T, Kurose S, Hisamatsu T, Ono A, et al. Differentiating autoimmune encephalitis from schizophrenia spectrum disorders among patients with first-episode psychosis. J Psychiatr Res. 2022;151:419\u201326.","journal-title":"J Psychiatr Res"},{"issue":"5","key":"4078_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0196-0644(81)80047-9","volume":"10","author":"MM McCarron","year":"1981","unstructured":"McCarron MM, Schulze BW, Thompson GA, Conder MC, Goetz WA. Acute phencyclidine intoxication: incidence of clinical findings in 1,000 cases. Ann Emerg Med. 1981;10(5):237\u201342.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"4078_CR24","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.mehy.2011.06.041","volume":"77","author":"A Pikwer","year":"2011","unstructured":"Pikwer A. Depersonalization disorder may be related to glutamate receptor activation imbalance. Med Hypotheses. 2011;77(4):593\u20134.","journal-title":"Med Hypotheses"},{"issue":"1","key":"4078_CR25","first-page":"53","volume":"27","author":"A Mechri","year":"2001","unstructured":"Mechri A, Saoud M, Khiari G, d\u2019Amato T, Dalery J, Gaha L. Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine. Encephale. 2001;27(1):53\u20139.","journal-title":"Encephale"},{"key":"4078_CR26","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1192\/bjp.bp.105.015263","volume":"189","author":"E Pomarol-Clotet","year":"2006","unstructured":"Pomarol-Clotet E, Honey GD, Murray GK, Corlett PR, Absalom AR, Lee M, et al. Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry. 2006;189:173\u20139.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"4078_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s00415-014-7600-8","volume":"262","author":"J Varley","year":"2015","unstructured":"Varley J, Vincent A, Irani SR. Clinical and experimental studies of potentially pathogenic brain-directed autoantibodies: current knowledge and future directions. J Neurol. 2015;262(4):1081\u201395.","journal-title":"J Neurol"},{"issue":"8","key":"4078_CR28","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.braindev.2013.10.005","volume":"36","author":"K Miya","year":"2014","unstructured":"Miya K, Takahashi Y, Mori H. Anti-NMDAR autoimmune encephalitis. Brain Dev. 2014;36(8):645\u201352.","journal-title":"Brain Dev"},{"issue":"5\u20136","key":"4078_CR29","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/13554794.2019.1573260","volume":"24","author":"M Funayama","year":"2018","unstructured":"Funayama M, Mizushima J, Takata T, Koreki A, Mimura M. Altered perception might be a symptom of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis. Neurocase. 2018;24(5\u20136):255\u20138.","journal-title":"Neurocase"},{"issue":"7872","key":"4078_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0140-6736(74)91639-0","volume":"2","author":"G Teasdale","year":"1974","unstructured":"Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2(7872):81\u20134.","journal-title":"Lancet"},{"issue":"2","key":"4078_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1447-0594.2011.00772.x","volume":"12","author":"Y Ideno","year":"2012","unstructured":"Ideno Y, Takayama M, Hayashi K, Takagi H, Sugai Y. Evaluation of a Japanese version of the Mini-mental State examination in elderly persons. Geriatr Gerontol Int. 2012;12(2):310\u20136.","journal-title":"Geriatr Gerontol Int"},{"issue":"10","key":"4078_CR32","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1161\/STROKEAHA.109.557256","volume":"40","author":"TJ Quinn","year":"2009","unstructured":"Quinn TJ, Dawson J, Walters MR, Lees KR. Reliability of the modified Rankin Scale: a systematic review. Stroke. 2009;40(10):3393\u20135.","journal-title":"Stroke"},{"issue":"4","key":"4078_CR33","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1159\/000091226","volume":"21","author":"Y Shinohara","year":"2006","unstructured":"Shinohara Y, Minematsu K, Amano T, Ohashi Y. Modified Rankin scale with expanded guidance scheme and interview questionnaire: interrater agreement and reproducibility of assessment. Cerebrovasc Dis. 2006;21(4):271\u20138.","journal-title":"Cerebrovasc Dis"},{"issue":"Pt 3","key":"4078_CR34","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/brain\/awr210","volume":"135","author":"MJ Allman","year":"2012","unstructured":"Allman MJ, Meck WH. Pathophysiological distortions in time perception and timed performance. Brain. 2012;135(Pt 3):656\u201377.","journal-title":"Brain"},{"issue":"5","key":"4078_CR35","doi-asserted-by":"publisher","first-page":"567","DOI":"10.2174\/18715273113129990080","volume":"12","author":"S Teixeira","year":"2013","unstructured":"Teixeira S, Machado S, Paes F, Velasques B, Silva JG, Sanfim AL, et al. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2013;12(5):567\u201382.","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"1","key":"4078_CR36","first-page":"45","volume":"42","author":"G Stanghellini","year":"2016","unstructured":"Stanghellini G, Ballerini M, Presenza S, Mancini M, Raballo A, Blasi S, et al. Psychopathology of Lived Time: abnormal time experience in persons with Schizophrenia. Schizophr Bull. 2016;42(1):45\u201355.","journal-title":"Schizophr Bull"},{"issue":"8","key":"4078_CR37","first-page":"801","volume":"147","author":"L Fouks","year":"1989","unstructured":"Fouks L, Guibert S, Montot M. Minkowski\u2019s concept of lived time. Ann Med Psychol (Paris). 1989;147(8):801\u20139.","journal-title":"Ann Med Psychol (Paris)"},{"key":"4078_CR38","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3389\/fnhum.2018.00132","volume":"12","author":"B Martin","year":"2018","unstructured":"Martin B, Franck N, Cermolacce M, Coull JT, Giersch A. Minimal self and timing disorders in Schizophrenia: a Case Report. Front Hum Neurosci. 2018;12:132.","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"4078_CR39","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1155\/1990\/290159","volume":"3","author":"J Cutting","year":"1990","unstructured":"Cutting J, Silzer H. Psychopathology of time in brain disease and schizophrenia. Behav Neurol. 1990;3(4):197\u2013215.","journal-title":"Behav Neurol"},{"key":"4078_CR40","doi-asserted-by":"publisher","first-page":"668633","DOI":"10.3389\/fpsyt.2021.668633","volume":"12","author":"JD Blom","year":"2021","unstructured":"Blom JD, Nanuashvili N, Waters F. Time distortions: a systematic review of cases characteristic of Alice in Wonderland Syndrome. Front Psychiatry. 2021;12:668633.","journal-title":"Front Psychiatry"},{"issue":"3","key":"4078_CR41","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1212\/CPJ.0000000000000251","volume":"6","author":"JD Blom","year":"2016","unstructured":"Blom JD. Alice in Wonderland syndrome: a systematic review. Neurol Clin Pract. 2016;6(3):259\u201370.","journal-title":"Neurol Clin Pract"},{"key":"4078_CR42","doi-asserted-by":"publisher","first-page":"8243145","DOI":"10.1155\/2016\/8243145","volume":"2016","author":"G Mastria","year":"2016","unstructured":"Mastria G, Mancini V, Vigan\u00f2 A, Di Piero V. Alice in Wonderland Syndrome: a clinical and pathophysiological review. Biomed Res Int. 2016;2016:8243145.","journal-title":"Biomed Res Int"},{"key":"4078_CR43","unstructured":"Giannotti AM. S\u00edndrome De Alicia en El Pa\u00eds De Las Maravillas E infecci\u00f3n por virus de Epstein Barr. Arch. Argent. Pediatr; 2003. pp. 41\u20133."},{"issue":"6","key":"4078_CR44","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/S1695-4033(01)77603-5","volume":"54","author":"C P\u00e9rez M\u00e9ndez","year":"2001","unstructured":"P\u00e9rez M\u00e9ndez C, Mart\u00edn Mardomingo M, Otero Mart\u00ednez B, Lagunilla Herrero L, Fern\u00e1ndez Zurita C. [Alice in Wonderland syndrome due to Epstein-Barr virus infection]. Esp Pediatr. 2001;54(6):601\u20132.","journal-title":"Esp Pediatr"},{"issue":"2","key":"4078_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/PEC.0b013e318209af7a","volume":"27","author":"A Augarten","year":"2011","unstructured":"Augarten A, Aderka D. Alice in Wonderland syndrome in H1N1 influenza: case report. Pediatr Emerg Care. 2011;27(2):120.","journal-title":"Pediatr Emerg Care"},{"key":"4078_CR46","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.jtauto.2022.100165","volume":"5","author":"N Hansen","year":"2022","unstructured":"Hansen N. NMDAR autoantibodies in psychiatric disease - an immunopsychiatric continuum and potential predisposition for disease pathogenesis. J Transl Autoimmun. 2022;5:100165.","journal-title":"J Transl Autoimmun"},{"issue":"10","key":"4078_CR47","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/S2215-0366(24)00282-7","volume":"11","author":"N Hansen","year":"2024","unstructured":"Hansen N, Luedecke D, Maier HB, Neyazi A, Fitzner D, Wiltfang J, Malchow B. NMDAR1 autoantibodies as potential biomarkers for schizophrenia phenotyping. Lancet Psychiatry. 2024;11(10):780\u20131.","journal-title":"Lancet Psychiatry"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-025-04078-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-025-04078-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:20:21Z","timestamp":1740360021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-025-04078-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4078"],"URL":"https:\/\/doi.org\/10.1186\/s12883-025-04078-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,24]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient participant (the study case) for the publication of any potentially identifiable data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"75"}}